Arkolith/Insider Trading/TAK/Form 4

Pignagnoli Agosti Marcello

Head, Strat. & Port. Dev.TAKEDA PHARMACEUTICAL CO LTD (TAK) · full profile →Form 4 · filed Apr 28, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2026Grant(A)28K—$0172K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001395064-26-000124) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML